Cargando…

Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels

Few studies have paid attention to the performances of non-invasive models in diagnosing stages of liver fibrosis and inflammation, which are critical for early and accurate assessment of prognostication and decisions on antiviral treatment in chronic hepatitis B infection patients with high hepatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lingmei, Li, Jiao, Yang, Kai, Zhang, Hao, Wang, Qin, Lv, Xiongwen, Guan, Shihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306294/
https://www.ncbi.nlm.nih.gov/pubmed/32502018
http://dx.doi.org/10.1097/MD.0000000000020548
_version_ 1783548625745346560
author Wang, Lingmei
Li, Jiao
Yang, Kai
Zhang, Hao
Wang, Qin
Lv, Xiongwen
Guan, Shihe
author_facet Wang, Lingmei
Li, Jiao
Yang, Kai
Zhang, Hao
Wang, Qin
Lv, Xiongwen
Guan, Shihe
author_sort Wang, Lingmei
collection PubMed
description Few studies have paid attention to the performances of non-invasive models in diagnosing stages of liver fibrosis and inflammation, which are critical for early and accurate assessment of prognostication and decisions on antiviral treatment in chronic hepatitis B infection patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels (≤2 times upper limit of normal (ULN)). This study aimed to investigate the value of routine serum markers in evaluation of liver inflammation and fibrosis in these patients. A total of 370 consecutive chronic hepatitis B virus-infected patients who underwent liver biopsy were retrospectively analyzed. The Scheuer scoring system was adopted as the pathological standard for diagnosing liver inflammation and fibrosis. The receiver-operating characteristic curves (ROC) and the area under the ROC curves (AUROCs) were used to analyze the performances of the models, including aspartate transaminase to platelet ratio index (APRI), fibrosis index based on the 4 factors (FIB-4), red cell volume distribution width-to-platelet ratio (RPR), globulin-platelet model (GP), and gamma-glutamyl transpeptidase to platelet ratio index (GPR). To predict significant inflammation (G ≥2), the AUROC of APRI was higher than that of FIB-4 (0.705 vs 0.629, P = .001), RPR (0.705 vs 0.593, P < .001) and GP (0.705 vs 0.620, P = .002), equivalent to that of GPR (0.705 vs 0.690, P = .606). As for severe inflammation (≥G3) and significant fibrosis (≥S2), there was no statistic difference among them. To predict severe fibrosis (≥ S3), the AUROC of FIB-4 was higher than that of RPR (0.805 vs 0.750, P = .006) and GP (0.805 vs 0.755, P = .046), comparable to that of APRI (0.805 vs 0.785, P = .550) and GPR (0.805 vs 0.818, P = .694). As for significant liver histological changes (G ≥ 2 or/and S ≥ 2), the performance of APRI was higher than that of RPR (0.717 vs 0.652, P = .006), GP (0.717 vs 0.659, p = .011), equivalent to that of FIB-4 (0.717 vs 0.692, P = .254) and GPR (0.717 vs 0.680, P = .166). We found that APRI, GPR, and FIB-4 were more effective than RPR and GP for diagnosing liver inflammation and fibrosis.
format Online
Article
Text
id pubmed-7306294
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-73062942020-07-08 Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels Wang, Lingmei Li, Jiao Yang, Kai Zhang, Hao Wang, Qin Lv, Xiongwen Guan, Shihe Medicine (Baltimore) 4500 Few studies have paid attention to the performances of non-invasive models in diagnosing stages of liver fibrosis and inflammation, which are critical for early and accurate assessment of prognostication and decisions on antiviral treatment in chronic hepatitis B infection patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels (≤2 times upper limit of normal (ULN)). This study aimed to investigate the value of routine serum markers in evaluation of liver inflammation and fibrosis in these patients. A total of 370 consecutive chronic hepatitis B virus-infected patients who underwent liver biopsy were retrospectively analyzed. The Scheuer scoring system was adopted as the pathological standard for diagnosing liver inflammation and fibrosis. The receiver-operating characteristic curves (ROC) and the area under the ROC curves (AUROCs) were used to analyze the performances of the models, including aspartate transaminase to platelet ratio index (APRI), fibrosis index based on the 4 factors (FIB-4), red cell volume distribution width-to-platelet ratio (RPR), globulin-platelet model (GP), and gamma-glutamyl transpeptidase to platelet ratio index (GPR). To predict significant inflammation (G ≥2), the AUROC of APRI was higher than that of FIB-4 (0.705 vs 0.629, P = .001), RPR (0.705 vs 0.593, P < .001) and GP (0.705 vs 0.620, P = .002), equivalent to that of GPR (0.705 vs 0.690, P = .606). As for severe inflammation (≥G3) and significant fibrosis (≥S2), there was no statistic difference among them. To predict severe fibrosis (≥ S3), the AUROC of FIB-4 was higher than that of RPR (0.805 vs 0.750, P = .006) and GP (0.805 vs 0.755, P = .046), comparable to that of APRI (0.805 vs 0.785, P = .550) and GPR (0.805 vs 0.818, P = .694). As for significant liver histological changes (G ≥ 2 or/and S ≥ 2), the performance of APRI was higher than that of RPR (0.717 vs 0.652, P = .006), GP (0.717 vs 0.659, p = .011), equivalent to that of FIB-4 (0.717 vs 0.692, P = .254) and GPR (0.717 vs 0.680, P = .166). We found that APRI, GPR, and FIB-4 were more effective than RPR and GP for diagnosing liver inflammation and fibrosis. Wolters Kluwer Health 2020-06-05 /pmc/articles/PMC7306294/ /pubmed/32502018 http://dx.doi.org/10.1097/MD.0000000000020548 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 4500
Wang, Lingmei
Li, Jiao
Yang, Kai
Zhang, Hao
Wang, Qin
Lv, Xiongwen
Guan, Shihe
Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
title Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
title_full Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
title_fullStr Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
title_full_unstemmed Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
title_short Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
title_sort comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis b virus-infected patients with high hepatitis b virus dna and normal or mildly elevated alanine transaminase levels
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306294/
https://www.ncbi.nlm.nih.gov/pubmed/32502018
http://dx.doi.org/10.1097/MD.0000000000020548
work_keys_str_mv AT wanglingmei comparisonandevaluationofnoninvasivemodelsinpredictingliverinflammationandfibrosisofchronichepatitisbvirusinfectedpatientswithhighhepatitisbvirusdnaandnormalormildlyelevatedalaninetransaminaselevels
AT lijiao comparisonandevaluationofnoninvasivemodelsinpredictingliverinflammationandfibrosisofchronichepatitisbvirusinfectedpatientswithhighhepatitisbvirusdnaandnormalormildlyelevatedalaninetransaminaselevels
AT yangkai comparisonandevaluationofnoninvasivemodelsinpredictingliverinflammationandfibrosisofchronichepatitisbvirusinfectedpatientswithhighhepatitisbvirusdnaandnormalormildlyelevatedalaninetransaminaselevels
AT zhanghao comparisonandevaluationofnoninvasivemodelsinpredictingliverinflammationandfibrosisofchronichepatitisbvirusinfectedpatientswithhighhepatitisbvirusdnaandnormalormildlyelevatedalaninetransaminaselevels
AT wangqin comparisonandevaluationofnoninvasivemodelsinpredictingliverinflammationandfibrosisofchronichepatitisbvirusinfectedpatientswithhighhepatitisbvirusdnaandnormalormildlyelevatedalaninetransaminaselevels
AT lvxiongwen comparisonandevaluationofnoninvasivemodelsinpredictingliverinflammationandfibrosisofchronichepatitisbvirusinfectedpatientswithhighhepatitisbvirusdnaandnormalormildlyelevatedalaninetransaminaselevels
AT guanshihe comparisonandevaluationofnoninvasivemodelsinpredictingliverinflammationandfibrosisofchronichepatitisbvirusinfectedpatientswithhighhepatitisbvirusdnaandnormalormildlyelevatedalaninetransaminaselevels